Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości INC
1.955+0.005(+0.26%)INC SPÓŁKA AKCYJNA
GPW - Akcje/PDA - Notowania ciągłe
Biznesradar bez reklam? Sprawdź BR Plus
**Nuwellis Inc Reports Q4 2025 Results**
The post Nuwellis Inc (NUWE) Reports Q4 Earnings first appeared on Alphastreet.
FreightCar America Inc (RAIL) delivered Q4 2025 adjusted earnings of -$0.17 per share, below analysts' $0.19 forecast (miss by 191.1%). Revenue totaled $55...
The post FreightCar America Inc (RAIL) Misses Q4 EPS Estimates first appeared on Alphastreet.
**Voyager Technologies Inc Reports Q4 2025 Earnings**
The post Voyager Technologies Inc (VOYG) Reports Wider Q4 Loss Than Expected first appeared on Alphastreet.
**Tenax Therapeutics Narrows Q4 Loss, Beats Expectations**
The post Tenax Therapeutics Inc (TENX) Q4 Loss Widens, But Beats Estimates first appeared on Alphastreet.
KVH Industries Inc (KVHI) reported Q4 2025 gaap earnings of $0.02 per share. No consensus estimate was available for comparison. Revenue totaled $30.5M for...
The post KVH Industries Inc (KVHI) Reports Q4 Earnings first appeared on Alphastreet.
Nio Inc (NIO) delivered Q4 2025 gaap earnings of $0.29 per share, surpassing analysts' $0.05 forecast (beat by 441.4%). Top-line revenue was $4.61B. The Ch...
The post Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin first appeared on Alphastreet.
**BREAKING: Esperion Therapeutics Reports Q4 2025 Earnings Miss**
The post Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates first appeared on Alphastreet.
Protara Therapeutics, Inc. (TARA) posted a Q4 2025 gaap loss of $0.37 per share, wider than the -$0.31 expected loss (18.6% wider). The clinical-stage biop...
The post Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 first appeared on Alphastreet.
Inspired Entertainment, Inc (INSE) reported Q4 2025 gaap earnings of -$0.18 per share, missing the $0.21 consensus estimate (miss by 186.9%). The company g...
The post Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates first appeared on Alphastreet.
**Tenax Therapeutics Reports Q4 2025 Results**
The post Tenax Therapeutics Inc (TENX) Reports Q4 Earnings first appeared on Alphastreet.
**BREAKING: Esperion Therapeutics Reports Q4 2025 Results**
The post Esperion Therapeutics, Inc (ESPR) Reports Q4 Earnings first appeared on Alphastreet.
ABM Industries Inc (ABM) reported Q1 2026 gaap earnings of $0.83 per share, missing the $0.87 consensus estimate (miss by 4.8%). Revenue came in at $18.43B...
The post ABM Industries Inc (ABM) Misses Q1 EPS Estimates first appeared on Alphastreet.
Q32 Bio Inc. (QTTB) reported Q4 2025 adjusted earnings of $3.65 per share. No consensus estimate was available for comparison. Top-line revenue was $53.7M.
The post Q32 Bio Inc. (QTTB) Reports Q4 Earnings first appeared on Alphastreet.
Priority Technology Holdings, Inc (NASDAQ:PRTH) reported fourth quarter 2025 financial results. Q4 2025 adjusted earnings at Priority Technology Holdings, ...
The post Priority Technology Holdings, Inc (PRTH) Reports Q4 Earnings first appeared on Alphastreet.
**BREAKING: Prelude Therapeutics Reports Wider-Than-Expected Q4 Loss**
The post Prelude Therapeutics Inc (PRLD) Reports Wider Loss for FY25 vs. Estimates first appeared on Alphastreet.
**Cullinan Therapeutics Inc Reports Q4 2025 Results**
The post Cullinan Therapeutics Inc (CGEM) Reports Q4 Earnings first appeared on Alphastreet.
**BREAKING: Opus Genetics Inc. Reports Q4 2025 Results**
The post Opus Genetics Inc. (IRD) Reports FY25 Earnings first appeared on Alphastreet.
Analitycy DM INC widzą duży potencjał sprzedażowy gry "Lords of the Fallen 2". Wskazują oni, że tytuł może skorzystać zarówno z rosnącej bazy graczy związa...
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Informacje
| ISIN: | PLINCLT00015 |
|---|---|
| Data debiutu: | 09.08.2006 |
| Liczba akcji: | 15 043 099 |
| Kapitalizacja: | 29 409 259 |
| Enterprise Value: | 29 299 259 |
| Branża: | Działalność inwestycyjna |
INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom... INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom działającym w różnych sektorach. Poza prywatnymi przedsiębiorstwami, INC świadczy również usługi doradcze jednostkom samorządu terytorialnego oraz angażuje się w projekty sportowe, kulturalne i akademickie.
| Nazwa: | INC SPÓŁKA AKCYJNA |
|---|---|
| Adres: | ul. Abpa Antoniego Baraniaka 6, 61-131, Poznań, Polska |
| CEO: | Paweł Śliwiński |
| NIP: | 7781024498 |
| REGON: | 630316445 |
| KRS: | 0000028098 |
| Telefon: | +48 (61) 851 86 77 |
| WWW: | http://www.incsa.pl/ |
Biznesradar bez reklam? Sprawdź BR Plus
